首页 > 最新文献

medRxiv - Gastroenterology最新文献

英文 中文
The combination of SPP1 knockdown and gemcitabine treatment enhances apoptosis and reduces invasiveness of pancreatic cancer cells SPP1 基因敲除与吉西他滨联合治疗可增强胰腺癌细胞的凋亡并降低其侵袭性
Pub Date : 2024-05-06 DOI: 10.1101/2024.05.05.24306611
Ntombikayise Xelwa, Previn Naicker, Jones Omoshoro-Jones, John Devar, Martin Smith, Geoffrey Candy, Tanya Nadine Augustine, Ekene Emmanuel Nweke
Background Pancreatic ductal adenocarcinoma (PDAC) is poised to be a leading cause of cancer-related deaths. Despite developing new treatment strategies, patient outcomes have not significantly improved. Chemoresistance has been implicated as a major contributor to ineffective treatments observed with studies suggesting combination therapy targeting multiple pathways. This study explored dysregulated genes in tumours of PDAC patients to identify targets which could be used effectively in combination with conventional therapy against cancer cells.
背景 胰腺导管腺癌(PDAC)即将成为癌症相关死亡的主要原因。尽管开发了新的治疗策略,但患者的治疗效果并没有明显改善。化疗耐药性是导致治疗效果不佳的主要原因,有研究建议针对多种途径进行联合治疗。本研究探讨了 PDAC 患者肿瘤中的失调基因,以确定可与针对癌细胞的常规疗法有效结合使用的靶点。
{"title":"The combination of SPP1 knockdown and gemcitabine treatment enhances apoptosis and reduces invasiveness of pancreatic cancer cells","authors":"Ntombikayise Xelwa, Previn Naicker, Jones Omoshoro-Jones, John Devar, Martin Smith, Geoffrey Candy, Tanya Nadine Augustine, Ekene Emmanuel Nweke","doi":"10.1101/2024.05.05.24306611","DOIUrl":"https://doi.org/10.1101/2024.05.05.24306611","url":null,"abstract":"<strong>Background</strong> Pancreatic ductal adenocarcinoma (PDAC) is poised to be a leading cause of cancer-related deaths. Despite developing new treatment strategies, patient outcomes have not significantly improved. Chemoresistance has been implicated as a major contributor to ineffective treatments observed with studies suggesting combination therapy targeting multiple pathways. This study explored dysregulated genes in tumours of PDAC patients to identify targets which could be used effectively in combination with conventional therapy against cancer cells.","PeriodicalId":501258,"journal":{"name":"medRxiv - Gastroenterology","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140930640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Elevated polyreactive immunoglobulin G in immune mediated liver injuries with the need for immunosuppressive therapy 免疫介导的肝损伤中多反应性免疫球蛋白 G 的升高与免疫抑制疗法的必要性
Pub Date : 2024-05-06 DOI: 10.1101/2024.05.04.24306873
Theresa Kirchner, George N. Dalekos, Kalliopi Zachou, Mercedes Robles-Díaz, Raúl J. Andrade, Marcial Sebode, Ansgar Lohse, Maciej K. Janik, Piotr Milkiewicz, Mirjam Kolev, Nasser Semmo, Tony Bruns, Tom Jg Gevers, Benedetta Terziroli Beretta-Piccoli, Heiner Wedemeyer, Elmar Jaeckel, Richard Taubert, Bastian Engel, pIgG study group
Background and aim The distinction of drug-induced liver injury (DILI), drug-induced autoimmune-like hepatitis (DI-ALH) and autoimmune hepatitis (AIH) can be challenging due to overlapping clinical characteristics. Recently, polyreactive immunoglobulin G (pIgG) was identified as a novel biomarker with a higher accuracy for the diagnose of AIH than conventional autoantibodies. This retrospective multicenter study aimed to evaluate the diagnostic accuracy of pIgG to distinguish between AIH, DI-ALH and DILI and thus identify patients in need of immunosuppression.
背景和目的 由于药物性肝损伤(DILI)、药物性自身免疫性肝炎(DI-ALH)和自身免疫性肝炎(AIH)的临床特征相互重叠,因此将它们区分开来具有挑战性。最近,多反应性免疫球蛋白 G(pIgG)被认为是一种新型生物标记物,与传统的自身抗体相比,其诊断 AIH 的准确性更高。这项回顾性多中心研究旨在评估 pIgG 在区分 AIH、DI-ALH 和 DILI 方面的诊断准确性,从而确定需要接受免疫抑制的患者。
{"title":"Elevated polyreactive immunoglobulin G in immune mediated liver injuries with the need for immunosuppressive therapy","authors":"Theresa Kirchner, George N. Dalekos, Kalliopi Zachou, Mercedes Robles-Díaz, Raúl J. Andrade, Marcial Sebode, Ansgar Lohse, Maciej K. Janik, Piotr Milkiewicz, Mirjam Kolev, Nasser Semmo, Tony Bruns, Tom Jg Gevers, Benedetta Terziroli Beretta-Piccoli, Heiner Wedemeyer, Elmar Jaeckel, Richard Taubert, Bastian Engel, pIgG study group","doi":"10.1101/2024.05.04.24306873","DOIUrl":"https://doi.org/10.1101/2024.05.04.24306873","url":null,"abstract":"<strong>Background and aim</strong> The distinction of drug-induced liver injury (DILI), drug-induced autoimmune-like hepatitis (DI-ALH) and autoimmune hepatitis (AIH) can be challenging due to overlapping clinical characteristics. Recently, polyreactive immunoglobulin G (pIgG) was identified as a novel biomarker with a higher accuracy for the diagnose of AIH than conventional autoantibodies. This retrospective multicenter study aimed to evaluate the diagnostic accuracy of pIgG to distinguish between AIH, DI-ALH and DILI and thus identify patients in need of immunosuppression.","PeriodicalId":501258,"journal":{"name":"medRxiv - Gastroenterology","volume":"33 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140930635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The causal correlation between gastroesophageal reflux disease and chronic widespread pain: a bidirectional mendelian randomization study 胃食管反流病与慢性广泛性疼痛之间的因果关系:一项双向泯灭随机研究
Pub Date : 2024-05-06 DOI: 10.1101/2024.05.06.24306927
Menglin Chen, Houshu Tu, Jiaoli Zhou, Yi Zhang, Shuting Wen, Yao Xiao, Ling He
Background Previous observational research found a relationship between gastroesophageal reflux disease (GERD) and chronic widespread pain (CWP). Despite this, it is unknown which, if any, of the conditions produces the other. Our study will use bidirectional Mendelian randomization (MR) to evaluate their causal link.
背景 以往的观察性研究发现,胃食管反流病(GERD)与慢性广泛性疼痛(CWP)之间存在一定关系。尽管如此,目前还不清楚是哪种疾病导致了另一种疾病。我们的研究将采用双向孟德尔随机法(MR)来评估它们之间的因果关系。
{"title":"The causal correlation between gastroesophageal reflux disease and chronic widespread pain: a bidirectional mendelian randomization study","authors":"Menglin Chen, Houshu Tu, Jiaoli Zhou, Yi Zhang, Shuting Wen, Yao Xiao, Ling He","doi":"10.1101/2024.05.06.24306927","DOIUrl":"https://doi.org/10.1101/2024.05.06.24306927","url":null,"abstract":"<strong>Background</strong> Previous observational research found a relationship between gastroesophageal reflux disease (GERD) and chronic widespread pain (CWP). Despite this, it is unknown which, if any, of the conditions produces the other. Our study will use bidirectional Mendelian randomization (MR) to evaluate their causal link.","PeriodicalId":501258,"journal":{"name":"medRxiv - Gastroenterology","volume":"100 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140930426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of graph models to the identification of transcriptomic oncometabolic pathways in human hepatocellular carcinoma 应用图模型识别人类肝细胞癌的转录组代谢通路
Pub Date : 2024-05-02 DOI: 10.1101/2024.04.30.24306608
Sergio Barace, Eva Santamaría, Stefany Infante, Sara Arcelus, Jesús De la Fuente, Enrique Goñi, Ibon Tamayo, Idoia Ochoa, Miguel Sogbe, Bruno Sangro, Mikel Hernaez, Matías A. Ávila, Josepmaria Argemi
Whole tissue transcriptomic analyses have been helpful to characterize molecular subtypes of hepatocellular carcinoma (HCC). Metabolic subtypes of human HCC have been defined, yet whether these different metabolic classes are clinically relevant or derive in actionable cancer vulnerabilities is still an unanswered question. Publicly available gene sets or gene signatures have been used to infer functional changes through gene set enrichment methods. However, metabolism-related gene signatures are poorly coexpressed when applied to a biological context. Here, we apply a simple method to infer highly consistent signatures using graph models. Using The Cancer Genome Atlas Liver Hepatocellular cohort (LIHC), we describe the main metabolic clusters and their relationship with commonly used molecular classes, and with the presence of TP53 or CTNNB1 driver mutations. We find similar results in our validation cohort, the LIRI-JP cohort. We describe how previously described metabolic subtypes could not have therapeutic relevance due to their overall downregulation when compared to non-tumoral liver, and identify N-Glycan, Mevalonate and Sphingolipid biosynthetic pathways as the hallmark of the oncogenic shift of the use of Acetyl-coenzyme A in HCC metabolism. Finally, using DepMap data, we demonstrate metabolic vulnerabilities in HCC cell lines.
全组织转录组分析有助于描述肝细胞癌(HCC)的分子亚型。人类 HCC 的代谢亚型已经确定,但这些不同的代谢类别是否与临床相关或衍生出可操作的癌症弱点仍是一个未解之谜。公开的基因组或基因特征已被用于通过基因组富集方法推断功能性变化。然而,当应用于生物环境时,与代谢相关的基因特征的共表达很差。在此,我们采用一种简单的方法,利用图模型推断出高度一致的特征。通过癌症基因组图谱肝肝细胞队列(LIHC),我们描述了主要的代谢群及其与常用分子类别的关系,以及与 TP53 或 CTNNB1 驱动基因突变存在的关系。我们在验证队列 LIRI-JP 中也发现了类似的结果。我们描述了之前描述的代谢亚型如何因其与非肿瘤肝脏相比整体下调而不具有治疗意义,并确定了N-糖、甲羟戊酸和鞘磷脂生物合成途径是HCC代谢中乙酰辅酶A的使用发生致癌转变的标志。最后,我们利用 DepMap 数据证明了 HCC 细胞系的代谢脆弱性。
{"title":"Application of graph models to the identification of transcriptomic oncometabolic pathways in human hepatocellular carcinoma","authors":"Sergio Barace, Eva Santamaría, Stefany Infante, Sara Arcelus, Jesús De la Fuente, Enrique Goñi, Ibon Tamayo, Idoia Ochoa, Miguel Sogbe, Bruno Sangro, Mikel Hernaez, Matías A. Ávila, Josepmaria Argemi","doi":"10.1101/2024.04.30.24306608","DOIUrl":"https://doi.org/10.1101/2024.04.30.24306608","url":null,"abstract":"Whole tissue transcriptomic analyses have been helpful to characterize molecular subtypes of hepatocellular carcinoma (HCC). Metabolic subtypes of human HCC have been defined, yet whether these different metabolic classes are clinically relevant or derive in actionable cancer vulnerabilities is still an unanswered question. Publicly available gene sets or gene signatures have been used to infer functional changes through gene set enrichment methods. However, metabolism-related gene signatures are poorly coexpressed when applied to a biological context. Here, we apply a simple method to infer highly consistent signatures using graph models. Using The Cancer Genome Atlas Liver Hepatocellular cohort (LIHC), we describe the main metabolic clusters and their relationship with commonly used molecular classes, and with the presence of TP53 or CTNNB1 driver mutations. We find similar results in our validation cohort, the LIRI-JP cohort. We describe how previously described metabolic subtypes could not have therapeutic relevance due to their overall downregulation when compared to non-tumoral liver, and identify N-Glycan, Mevalonate and Sphingolipid biosynthetic pathways as the hallmark of the oncogenic shift of the use of Acetyl-coenzyme A in HCC metabolism. Finally, using DepMap data, we demonstrate metabolic vulnerabilities in HCC cell lines.","PeriodicalId":501258,"journal":{"name":"medRxiv - Gastroenterology","volume":"19 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140884339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical epidemiology of the endoscopic, laparoscopic, and surgical resection of malignant gastric tumors in Japan, 2014-2021: a retrospective study using open data from a national claims database 2014-2021年日本恶性胃肿瘤内镜、腹腔镜和手术切除的临床流行病学:一项利用全国索赔数据库公开数据进行的回顾性研究
Pub Date : 2024-05-01 DOI: 10.1101/2024.04.30.24305814
Akahito Sako, Tomoyuki Yada, Keiichi Fujiya, Ryo Nakashima, Kensuke Yoshimura, Hidekatsu Yanai, Naomi Uemura
Background Gastric cancer is one of the most common malignancies and its incidence is high in East Asia. Several options are available for resection of malignant gastric tumors, ranging from endoscopic resection of early-stage cancer to open total gastrectomy. However, there has been a lack of nationwide data on gastric resection in Japan.
背景 胃癌是最常见的恶性肿瘤之一,在东亚发病率很高。恶性胃肿瘤的切除术有多种选择,从早期癌症的内窥镜切除术到开腹全胃切除术。然而,日本一直缺乏有关胃切除术的全国性数据。
{"title":"Clinical epidemiology of the endoscopic, laparoscopic, and surgical resection of malignant gastric tumors in Japan, 2014-2021: a retrospective study using open data from a national claims database","authors":"Akahito Sako, Tomoyuki Yada, Keiichi Fujiya, Ryo Nakashima, Kensuke Yoshimura, Hidekatsu Yanai, Naomi Uemura","doi":"10.1101/2024.04.30.24305814","DOIUrl":"https://doi.org/10.1101/2024.04.30.24305814","url":null,"abstract":"<strong>Background</strong> Gastric cancer is one of the most common malignancies and its incidence is high in East Asia. Several options are available for resection of malignant gastric tumors, ranging from endoscopic resection of early-stage cancer to open total gastrectomy. However, there has been a lack of nationwide data on gastric resection in Japan.","PeriodicalId":501258,"journal":{"name":"medRxiv - Gastroenterology","volume":"13 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140884254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrative multi-omics characterization of hepatocellular carcinoma in Hispanic patients 西班牙裔患者肝细胞癌的多组学综合特征描述
Pub Date : 2024-04-30 DOI: 10.1101/2024.04.27.24306447
Debodipta Das, Xiaojing Wang, Yu-Chiao Chiu, Hakim Bouamar, Francis E. Sharkey, Jorge E. Lopera, Zhao Lai, Susan T. Weintraub, Xianlin Han, Yi Zou, Hung-I H. Chen, Carla R. Zeballos Torrez, Xiang Gu, Matyas Cserhati, Joel E. Michalek, Glenn A. Halff, Yidong Chen, Siyuan Zheng, Francisco G. Cigarroa, Lu-Zhe Sun
Background The incidence and mortality rates of hepatocellular carcinoma (HCC) among Hispanics in the United States are much higher than those of non-Hispanic whites. We conducted comprehensive multi-omics analyses to understand molecular alterations in HCC among Hispanic patients.
背景 美国拉美裔肝细胞癌(HCC)的发病率和死亡率远高于非拉美裔白人。我们进行了全面的多组学分析,以了解西班牙裔患者中 HCC 的分子改变。
{"title":"Integrative multi-omics characterization of hepatocellular carcinoma in Hispanic patients","authors":"Debodipta Das, Xiaojing Wang, Yu-Chiao Chiu, Hakim Bouamar, Francis E. Sharkey, Jorge E. Lopera, Zhao Lai, Susan T. Weintraub, Xianlin Han, Yi Zou, Hung-I H. Chen, Carla R. Zeballos Torrez, Xiang Gu, Matyas Cserhati, Joel E. Michalek, Glenn A. Halff, Yidong Chen, Siyuan Zheng, Francisco G. Cigarroa, Lu-Zhe Sun","doi":"10.1101/2024.04.27.24306447","DOIUrl":"https://doi.org/10.1101/2024.04.27.24306447","url":null,"abstract":"<strong>Background</strong> The incidence and mortality rates of hepatocellular carcinoma (HCC) among Hispanics in the United States are much higher than those of non-Hispanic whites. We conducted comprehensive multi-omics analyses to understand molecular alterations in HCC among Hispanic patients.","PeriodicalId":501258,"journal":{"name":"medRxiv - Gastroenterology","volume":"7 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140836490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deciphering the complex interplay between physical activity, inflammatory bowel disease and obesity/BMl through causal inference and mediation analyses 通过因果推理和中介分析,解读体育锻炼、炎症性肠病和肥胖症/BMl 之间复杂的相互作用
Pub Date : 2024-04-15 DOI: 10.1101/2024.04.15.24305823
Minjing Chang, Yuhui Zhao, Jun Qiao, Hongxia Li, Linlin Jia, Kaixin Yao, Nan Li, Peifeng He
Background and Aims Observational studies on the association between physical activity (PA) and inflammatory bowel diseases (IBDs), including Crohn’s disease (CD) and ulcerative colitis (UC), report inconsistent results. Moreover, the underlying mediator between PA and IBDs remains unknown. We aimed to investigate the causal effect of PA on IBD and the role of BMI as a mediator between PA and IBD.
背景和目的 有关体力活动(PA)与炎症性肠病(IBD)(包括克罗恩病(CD)和溃疡性结肠炎(UC))之间关系的观察性研究报告的结果并不一致。此外,PA 与 IBD 之间的潜在中介因素仍然未知。我们的目的是研究 PA 对 IBD 的因果效应以及 BMI 在 PA 和 IBD 之间的中介作用。
{"title":"Deciphering the complex interplay between physical activity, inflammatory bowel disease and obesity/BMl through causal inference and mediation analyses","authors":"Minjing Chang, Yuhui Zhao, Jun Qiao, Hongxia Li, Linlin Jia, Kaixin Yao, Nan Li, Peifeng He","doi":"10.1101/2024.04.15.24305823","DOIUrl":"https://doi.org/10.1101/2024.04.15.24305823","url":null,"abstract":"<strong>Background and Aims</strong> Observational studies on the association between physical activity (PA) and inflammatory bowel diseases (IBDs), including Crohn’s disease (CD) and ulcerative colitis (UC), report inconsistent results. Moreover, the underlying mediator between PA and IBDs remains unknown. We aimed to investigate the causal effect of PA on IBD and the role of BMI as a mediator between PA and IBD.","PeriodicalId":501258,"journal":{"name":"medRxiv - Gastroenterology","volume":"9 4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140610554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel genetic insights into the roles of amino acids in metabolic dysfunction-associated steatotic liver disease 氨基酸在代谢功能障碍相关脂肪性肝病中作用的新基因见解
Pub Date : 2024-04-12 DOI: 10.1101/2024.04.09.24305556
Jun Liu, Yuxuan Chen, Jin Qian, Ri Cui, Ayse Demirkan, Yihu Zheng
Background Previous research has suggested potential links between amino acids and metabolic dysfunction-associated steatotic liver disease (MASLD), but the precise roles of amino acids in MASLD development are not well understood. This study aimed to obtain insights into the relationships between circulating amino acids and MASLD.
背景 以前的研究表明,氨基酸与代谢功能障碍相关性脂肪性肝病(MASLD)之间存在潜在联系,但氨基酸在MASLD发病过程中的确切作用还不十分清楚。本研究旨在深入了解循环氨基酸与 MASLD 之间的关系。
{"title":"Novel genetic insights into the roles of amino acids in metabolic dysfunction-associated steatotic liver disease","authors":"Jun Liu, Yuxuan Chen, Jin Qian, Ri Cui, Ayse Demirkan, Yihu Zheng","doi":"10.1101/2024.04.09.24305556","DOIUrl":"https://doi.org/10.1101/2024.04.09.24305556","url":null,"abstract":"<strong>Background</strong> Previous research has suggested potential links between amino acids and metabolic dysfunction-associated steatotic liver disease (MASLD), but the precise roles of amino acids in MASLD development are not well understood. This study aimed to obtain insights into the relationships between circulating amino acids and MASLD.","PeriodicalId":501258,"journal":{"name":"medRxiv - Gastroenterology","volume":"283 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140581479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Limited Validity of Mayo Endoscopic Subscore in Ulcerative Colitis with Concomitant Primary Sclerosing Cholangitis 溃疡性结肠炎合并原发性硬化性胆管炎时梅奥内镜评分的有限有效性
Pub Date : 2024-04-10 DOI: 10.1101/2024.04.08.24305005
Pavel Wohl, Alzbeta Krausova, Petr Wohl, Ondrej Fabian, Lukas Bajer, Jan Brezina, Pavel Drastich, Mojmír Hlavaty, Petra Novotna, Michal Kahle, Julius Spicak, Martin Gregor
Background and Aims Ulcerative colitis (UC) with concomitant primary sclerosing cholangitis (PSC) represents a distinct disease entity (PSC-UC). Mayo endoscopic subscore (MES) is a standard tool for assessing disease activity in UC but its relevance in PSC-UC remains unclear. Here, we sought to compare MES in a cohort of UC and PSC-UC patients and assess the accuracy using histological activity scoring (Nancy histological index; NHI).
背景和目的 合并原发性硬化性胆管炎(PSC)的溃疡性结肠炎(UC)是一种独特的疾病实体(PSC-UC)。梅奥内镜评分(MES)是评估 UC 疾病活动性的标准工具,但其与 PSC-UC 的相关性仍不清楚。在这里,我们试图比较一组 UC 和 PSC-UC 患者的 MES,并使用组织学活动性评分(南希组织学指数;NHI)评估其准确性。
{"title":"Limited Validity of Mayo Endoscopic Subscore in Ulcerative Colitis with Concomitant Primary Sclerosing Cholangitis","authors":"Pavel Wohl, Alzbeta Krausova, Petr Wohl, Ondrej Fabian, Lukas Bajer, Jan Brezina, Pavel Drastich, Mojmír Hlavaty, Petra Novotna, Michal Kahle, Julius Spicak, Martin Gregor","doi":"10.1101/2024.04.08.24305005","DOIUrl":"https://doi.org/10.1101/2024.04.08.24305005","url":null,"abstract":"<strong>Background and Aims</strong> Ulcerative colitis (UC) with concomitant primary sclerosing cholangitis (PSC) represents a distinct disease entity (PSC-UC). Mayo endoscopic subscore (MES) is a standard tool for assessing disease activity in UC but its relevance in PSC-UC remains unclear. Here, we sought to compare MES in a cohort of UC and PSC-UC patients and assess the accuracy using histological activity scoring (Nancy histological index; NHI).","PeriodicalId":501258,"journal":{"name":"medRxiv - Gastroenterology","volume":"65 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140581582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pre-endoscopic screening of precancerous lesions in gastric cancer using deep learning 利用深度学习对胃癌癌前病变进行内镜前筛查
Pub Date : 2024-04-09 DOI: 10.1101/2024.04.08.24305062
Lan Wang, Qian Zhang, Peng Zhang, Bowen Wu, Shiyu Du, Kaiqiang Tang, Shao Li
Objective Given the high cost of endoscopy in gastric cancer (GC) screening, there is an urgent need to explore cost-effective methods for the large-scale prediction of precancerous lesions of gastric cancer (PLGC). We aim to construct a hierarchical artificial intelligence-based multimodal non-invasive method for pre-endoscopic risk screening, to provide tailored recommendations for endoscopy.
目的 鉴于胃癌(GC)筛查中内镜检查的高昂费用,迫切需要探索具有成本效益的方法来大规模预测胃癌癌前病变(PLGC)。我们旨在构建一种基于分层人工智能的多模态无创方法,用于内镜检查前的风险筛查,为内镜检查提供量身定制的建议。
{"title":"Pre-endoscopic screening of precancerous lesions in gastric cancer using deep learning","authors":"Lan Wang, Qian Zhang, Peng Zhang, Bowen Wu, Shiyu Du, Kaiqiang Tang, Shao Li","doi":"10.1101/2024.04.08.24305062","DOIUrl":"https://doi.org/10.1101/2024.04.08.24305062","url":null,"abstract":"<strong>Objective</strong> Given the high cost of endoscopy in gastric cancer (GC) screening, there is an urgent need to explore cost-effective methods for the large-scale prediction of precancerous lesions of gastric cancer (PLGC). We aim to construct a hierarchical artificial intelligence-based multimodal non-invasive method for pre-endoscopic risk screening, to provide tailored recommendations for endoscopy.","PeriodicalId":501258,"journal":{"name":"medRxiv - Gastroenterology","volume":"27 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140602640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
medRxiv - Gastroenterology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1